Pharmacological options for pain control in patients with vertebral fragility fractures

Nuttan Kantilal Tanna; Terence Ong

doi:10.1016/j.afos.2022.09.003

Pharmacological options for pain control in patients with vertebral fragility fractures

Osteoporos Sarcopenia. 2022 Sep;8(3):93-97. doi: 10.1016/j.afos.2022.09.003. Epub 2022 Oct 3.

Authors

Nuttan Kantilal Tanna¹, Terence Ong^{2

3}

Affiliations

¹ Northwick Park Hospital, London North West University Healthcare NHS Trust, London, United Kingdom.
² Department of Medicine, Faculty of Medicine, University Malaya, 50603, Kuala Lumpur, Malaysia.
³ School of Medicine, Taylor's University, 47100 Selangor, Malaysia.

Abstract

This review considers the evidence base and current knowledge for pharmacological treatment options that are available for pain control in patients with vertebral fractures sustained after a low trauma incident. Due care needs to be taken when considering prescribed options for pain control. The decision should be based on first establishing whether the presentation is one of acute severe pain at the time of a new vertebral fragility fracture incident or whether the complaint is one of the debilitating, longer term chronic back pain syndrome, accompanied by a clinical suspicion of a possible new fracture. The article also presents currently debated questions in this important area of clinical and patient care and will be of interest to the readership worldwide.

Keywords: Analgesia; Opioid; Osteoporosis; Pain; Vertebral fracture.

Publication types

Review